Ocumension Therapeutics (HKSE:01477) Shares Buyback Ratio % : -0.28 (As of Apr. 25, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Ocumension Therapeutics's current shares buyback ratio was -0.28%.

Ocumension Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Ocumension Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Shares Buyback Ratio % Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-2.76

-12.79

-3.30

-0.28

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Shares Buyback Ratio %	Get a 7-Day Free Trial						-5.63	-0.16	-3.14	-0.29	0.01

Ocumension Therapeutics Shares Buyback Ratio % Calculation

Ocumension Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2021 )	-	Shares Outstanding (EOP) (A: Dec. 2022 ))	/	Shares Outstanding (EOP) (A: Dec. 2021 )
	=	(666.743	-	688.737)	/	666.743
	=	-3.30%

Ocumension Therapeutics's Shares Buyback Ratio for the quarter that ended in Jun. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Jun. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(688.737	-	690.711)	/	688.737
	=	-0.29%

Ocumension Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines